Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 3
2009 2
2010 3
2011 2
2012 3
2013 1
2014 1
2015 1
2019 3
2020 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for naganuma mh
Search for Mwaganyuma MH instead (1 results)
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
Nakase H, Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Takeuchi K, Tamura S, Kinjo F, Ueno N, Naganuma M, Watanabe K, Moroi R, Nishimata N, Motoya S, Kurahara K, Takahashi S, Maemoto A, Sakuraba H, Saruta M, Tominaga K, Hisabe T, Tanaka H, Terai S, Hiraoka S, Takedomi H, Narimatsu K, Endo K, Nakamura M, Hisamatsu T. Nakase H, et al. J Gastroenterol. 2023 Mar;58(3):205-216. doi: 10.1007/s00535-022-01949-6. Epub 2023 Jan 6. J Gastroenterol. 2023. PMID: 36607399 Free PMC article.
Cost of depression among adults in Japan in 2005.
Sado M, Yamauchi K, Kawakami N, Ono Y, Furukawa TA, Tsuchiya M, Tajima M, Kashima H; WMH-J2002-2006 Survey Group; Nakane Y, Nakamura Y, Fukao A, Horiguchi I, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Oorui M, Funayama K, Naganuma Y, Hata Y, Kobayashi M, Ahiko T, Yamamoto Y, Takeshima T, Kikkawa T. Sado M, et al. Psychiatry Clin Neurosci. 2011 Aug;65(5):442-50. doi: 10.1111/j.1440-1819.2011.02237.x. Psychiatry Clin Neurosci. 2011. PMID: 21851453 Free article.
Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials.
Hibi T, Naganuma M, Oda E, Yamada Y, Chujoh Y, Yoshihara R, Watanabe M. Hibi T, et al. Intest Res. 2020 Jan;18(1):56-68. doi: 10.5217/ir.2019.00064. Epub 2019 Dec 11. Intest Res. 2020. PMID: 31813214 Free PMC article.
BACKGROUND/AIMS: Mucosal healing (MH) of distal lesions in ulcerative colitis (UC) has recently been confirmed with budesonide 2-mg foam (BF) treatment in 2 clinical trials; however, few studies have investigated the predictive factors for complete MH. ...The relati …
BACKGROUND/AIMS: Mucosal healing (MH) of distal lesions in ulcerative colitis (UC) has recently been confirmed with budesonide 2-mg f …
Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Abe T, Suzuki Y, Kanai T; INDIGO Study Group. Naganuma M, et al. J Gastroenterol. 2020 Feb;55(2):169-180. doi: 10.1007/s00535-019-01625-2. Epub 2019 Sep 16. J Gastroenterol. 2020. PMID: 31529220 Clinical Trial.

We also analyzed factors predicting CR and MH at week 8. RESULTS: The rates of CR of IN group were significantly higher than placebo group, even in patients with steroid-dependent disease (p < 0.001), previous use of anti-TNF-alpha (p = 0.002), and concomitant use of IM

…
We also analyzed factors predicting CR and MH at week 8. RESULTS: The rates of CR of IN group were significantly higher than placebo …
Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
Fukuda T, Naganuma M, Sugimoto S, Ono K, Nanki K, Mizuno S, Kimura K, Mutaguchi M, Nakazato Y, Takabayashi K, Inoue N, Ogata H, Iwao Y, Kanai T. Fukuda T, et al. Inflamm Bowel Dis. 2019 Mar 14;25(4):782-788. doi: 10.1093/ibd/izy300. Inflamm Bowel Dis. 2019. PMID: 30265308
BACKGROUND: Mucosal healing (MH) is proposed as a therapeutic target for ulcerative colitis (UC). ...
BACKGROUND: Mucosal healing (MH) is proposed as a therapeutic target for ulcerative colitis (UC). ...
21 results